№ files_lp_4_process_2_47611
File format: docx Character count: 6717 File size: 1296 KB
Supplementary source detailing experimental procedures, characterization, and anti-cancer testing of NiCuFe-S nanoparticles including photothermal and catalytic assessments, in vitro cell experiments, and analytical measurements.
Year: 2026
Region / City: Shanghai, Beijing, Jiangsu, China
Subject: Nanomaterials, Photothermal Therapy, Catalysis, Anti-Cancer Studies
Document Type: Supplementary Materials
Institution: Sinopharm Chemical Reagent Co., Ltd.; Aladdin Biochemical Technology Co., Ltd.; KeyGEN BioTECH Co., Ltd.
Authors: Not specified
Target Audience: Researchers in nanotechnology and biomedical sciences
Experimental Models: In vitro cell lines (Hela, NRK-52E), in vivo animal experiments
Techniques: TEM, FETEM, SEM, UV-vis spectroscopy, XRD, EPR, CLSM, Flow Cytometry, Western Blot
Materials: NiCuFe-S nanoparticles, Doxorubicin hydrochloride, Thiol PEG amine, TMB, cell culture media
Laser Parameters: 808 nm and 1064 nm NIR lasers, IR camera measurements
Data Types: Photothermal conversion efficiency, catalytic activity, cell viability, ROS levels, protein expression
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.

The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Systemic anti-cancer therapy for advanced non-small-cell lung cancer
Year: 2023
Region / city: UK
Theme: Oncology, Lung Cancer, Treatment Guidelines
Document type: Clinical guidelines
Organization / institution: NICE
Author: NICE
Target audience: Healthcare professionals
Period of validity: Not specified
Approval date: Not specified
Date of changes: Not specified
Contextual description: Detailed clinical guidelines outlining the recommended systemic treatments for advanced non-small-cell lung cancer based on disease progression and previous therapies.
Management of Systemic Anti-cancer Therapy (SACT) Induced Diarrhoea in Adult Patients
Year: 2024
Region / city: West Midlands
Topic: Cancer treatment-induced diarrhoea management
Document Type: Guideline
Organization / Institution: West Midlands Cancer Alliance
Authors: Nicky Adams, Dr V Kunene, Dr C Mikropoulos
Target Audience: Healthcare professionals
Period of validity: 2024-2026
Approval Date: 16/09/2024
Revision Date: 30/09/2024
Review Date: 30/09/2026
Version: 4.0
Guideline purpose: Assessment and management of systemic anti-cancer therapy (SACT) induced diarrhoea
Key Amendments: Updated management guidance, updated antibiotic use, and self-management tips included
Scope: Prevention and management of diarrhoea in adult patients receiving SACT including immunotherapy
Background: High risk of diarrhoea (up to 80%) with certain chemotherapy agents
Patient care aim: Minimise morbidity and reduce mortality risk related to SACT-induced diarrhoea
Objective: Improve patient quality of life and ensure effective management of diarrhoea
Proposed Colorectal cancer systemic anti-cancer therapy (chemotherapy) regimens: Draft definitions for review 2019
Year: 2019
Region / City: Wellington, New Zealand
Topic: Colorectal cancer, chemotherapy regimens
Document type: Draft definitions
Organization / Institution: Ministry of Health, New Zealand
Author: Ministry of Health
Target audience: Medical oncologists, pharmacists, nurse specialists, other DHB staff
Period of validity: Not specified
Approval date: Not specified
Date of last modification: Not specified
Systemic anti-cancer therapy for advanced non-small-cell lung cancer: accessible summary
Year: 2024
Note: Region / city
Subject: Oncology, Lung Cancer
Document Type: Clinical Guidelines
Organization / Institution: NICE
Target Audience: Healthcare Professionals
New guidance brings clarity to environmental hazard and behavior testing of nanomaterials
Year: 2020
Region / City: Berlin, Germany
Topic: Nanomaterials, Ecotoxicity Testing, Environmental Safety
Document Type: Guidance Document
Author: Elijah Joel Petersen, Greg Gerard Goss, Frank von der Kammer, Alan James Kennedy
Target Audience: Researchers, Regulatory Agencies, Environmental Scientists
Effective Period: 2014-2020
Approval Date: July 2020
Revision Date: N/A
CALL FOR PARTICIPATIONCSIR Nanomaterials Industry Development Facility
Year: 2023
Region / City: South Africa
Field: Nanotechnology, Chemical Engineering, Polymer Science
Document Type: Call for Participation / Invitation
Organization: CSIR (Council for Scientific and Industrial Research)
Target Audience: Small, medium, and micro enterprises (SMMEs), private companies, higher education institutions
Period of Action: Ongoing
Approval Date: Not specified
Date of Changes: Not specified
Standard Operating Procedure for Work with Nanomaterials
Chemical name/class: Nanomaterials (customization required)
CAS #: Not specified
Principal Investigator (PI): Not specified
Date: Not specified
Building: Not specified
Room #: Not specified
Designated Work Area: Required
Circumstances of Use: Laboratory handling of nanomaterials including synthesis, weighing, suspension preparation, and potential aerosol-generating procedures
Particle Size: 100 nm or less in at least one dimension
Hazard Category: Potentially toxic, flammable, explosive, or reactive depending on composition
Routes of Exposure: Skin contact, inhalation, ingestion, injection
Engineering Controls: Chemical fume hood, exhausted biological safety cabinet, or other exhausted enclosure; possible HEPA filtration
Work Practice Controls: Laboratory-specific written procedures; designated work area; wet cleaning or HEPA vacuuming; container labeling with particle size
Personal Protective Equipment: Nitrile gloves, lab coat, safety glasses or goggles, face shield if splash risk, Tyvek sleeves or gown if necessary
Transportation Requirements: Sealed shatter-resistant primary container or secondary containment
Storage Requirements: Labeled containers indicating composition, particle size, and hazards; segregation from incompatibles; protection from heat and open flame if applicable
Waste Disposal Policy: Disposal in accordance with laboratory chemical hygiene plan, Duke University Chemical Waste Policy, and Laboratory Chemical Waste Management Practices
Environmental Health Contact: Occupational and Environmental Safety Office (OESO)
Medical Contact: Employee Occupational Health and Wellness (EOHW)
Emergency Procedures: Eye or skin flushing for 15 minutes; evacuation in case of inhalation risk; emergency contact via campus police or designated numbers
Spill Response: Activation of institutional spill response procedures and OESO spill team
Surface-tailored nanomaterials for enzyme immobilization: hybrid, stable, and recyclable biocatalysts
Year: 2025
Region / City: Torino, Italy; Pavia, Italy; Valencia, Spain; Ås, Norway; Christchurch, New Zealand
Field: Biocatalysis, Chemical Engineering
Document type: Research article
Organization / Institution: University of Torino, Universitat Politècnica de València, Norwegian University of Life Sciences, University of Canterbury
Authors: C. Pontremoli, F. Careddu, S. Rojas-Buzo, Kelsi R. Hall, M. Sørlie, V. G. H. Eijsink, N. Barbero, F. Bonino, C. Barolo, S. Bordiga
Target audience: Researchers, academicians, professionals in biocatalysis and chemical engineering
Effective period: 2025 and beyond
Date of approval: Not specified
Date of amendments: Not specified
Natural water properties of carbon-based nanomaterials
Year: Not specified
Region / City: Not specified
Theme: Carbon-based nanomaterials, water properties
Document Type: Scientific data
Organization / Institution: Not specified
Author: Not specified
Target Audience: Researchers, scientists
Effective Period: Not specified
Approval Date: Not specified
Modification Date: Not specified
Topics: NiCuFe-S anti-cancer nanomaterials